HIV prevention drug hailed as breakthrough, but who gets access? | Science and Technology News
A medicine injected just twice a year could transform the fight against HIV. In a 2024 clinical trial involving more than 2,000 young women in South Africa and Uganda, no participants who received lenacapavir contracted HIV. Recommended Stories list of 4 itemsend of list Developed by United States pharmaceutical company Gilead Sciences, the injectable drug…
Russian drone hits school in Ukraine’s Kyiv as Moscow presses air assault | NATO News
Russian drone strikes hit a school in Kyiv and the main bridge, disrupting transport in the latest wave of attacks. Published On 1 Oct 20261 Oct 2026 A Russian drone has struck a school in Kyiv, officials said, as the Ukrainian capital endured another day of bombardment. Kyiv Mayor Vitali Klitschko said children and staff…
